Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Evolan Pharma AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 960,999 Less Arrow 697,061 Less Arrow 652,113
Financial expenses 8,579 Less Arrow 1,668 Less Arrow 1,316
Earnings before taxes 291,278 Less Arrow 221,228 Less Arrow 190,100
EBITDA 405,260 Less Arrow 290,042 Less Arrow 258,460
Total assets 1,030,730 Less Arrow 816,768 Less Arrow 538,601
Current assets 753,699 Less Arrow 465,538 Less Arrow 345,072
Current liabilities 230,575 Less Arrow 202,186 Less Arrow 149,274
Equity capital 740,494 Less Arrow 498,965 Less Arrow 356,677
- share capital 101 Less Arrow 95 More Arrow 98
Employees (average) 29 Less Arrow 27 Equal arrow 27

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 71.8% Less Arrow 61.1% More Arrow 66.2%
Turnover per employee 33,138 Less Arrow 25,817 Less Arrow 24,152
Profit as a percentage of turnover 30.3% More Arrow 31.7% Less Arrow 29.2%
Return on assets (ROA) 29.1% Less Arrow 27.3% More Arrow 35.5%
Current ratio 326.9% Less Arrow 230.3% More Arrow 231.2%
Return on equity (ROE) 39.3% More Arrow 44.3% More Arrow 53.3%
Change turnover 214,477 Less Arrow 64,547 More Arrow 122,165
Change turnover % 29% Less Arrow 10% More Arrow 23%
Chg. No. of employees 2 Less Arrow 0 Equal arrow 0
Chg. No. of employees % 7% Less Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.